Concepts (99)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Heart Failure | 14 | 2023 | 1160 | 4.510 |
Why?
|
| Heart-Assist Devices | 8 | 2023 | 716 | 2.820 |
Why?
|
| Shock, Cardiogenic | 3 | 2023 | 85 | 1.060 |
Why?
|
| Cardiotonic Agents | 1 | 2023 | 84 | 0.920 |
Why?
|
| Hemodynamics | 8 | 2023 | 701 | 0.840 |
Why?
|
| Spironolactone | 1 | 2021 | 23 | 0.830 |
Why?
|
| Ventricular Outflow Obstruction | 1 | 2020 | 21 | 0.770 |
Why?
|
| Defibrillators, Implantable | 2 | 2021 | 129 | 0.750 |
Why?
|
| Sex Factors | 1 | 2023 | 1040 | 0.750 |
Why?
|
| Cardiomyopathies | 2 | 2020 | 237 | 0.710 |
Why?
|
| Prosthesis Implantation | 1 | 2020 | 123 | 0.700 |
Why?
|
| HIV | 1 | 2018 | 44 | 0.660 |
Why?
|
| Electrophysiologic Techniques, Cardiac | 1 | 2018 | 39 | 0.650 |
Why?
|
| Antiretroviral Therapy, Highly Active | 1 | 2018 | 64 | 0.650 |
Why?
|
| Bundle-Branch Block | 1 | 2017 | 47 | 0.620 |
Why?
|
| Pacemaker, Artificial | 1 | 2018 | 86 | 0.620 |
Why?
|
| Cardiac Resynchronization Therapy | 1 | 2017 | 66 | 0.600 |
Why?
|
| Heart Atria | 1 | 2018 | 238 | 0.580 |
Why?
|
| Health Status | 1 | 2018 | 353 | 0.560 |
Why?
|
| Atrial Fibrillation | 1 | 2018 | 269 | 0.510 |
Why?
|
| Cardiac Output | 3 | 2022 | 152 | 0.470 |
Why?
|
| Aortic Valve Insufficiency | 2 | 2023 | 129 | 0.430 |
Why?
|
| Humans | 22 | 2023 | 84398 | 0.390 |
Why?
|
| Pulmonary Wedge Pressure | 2 | 2021 | 108 | 0.390 |
Why?
|
| HIV Infections | 1 | 2018 | 741 | 0.370 |
Why?
|
| Heart Transplantation | 2 | 2023 | 694 | 0.300 |
Why?
|
| Global Health | 2 | 2018 | 192 | 0.300 |
Why?
|
| Intra-Aortic Balloon Pumping | 2 | 2023 | 78 | 0.260 |
Why?
|
| Heart Valve Prosthesis | 1 | 2023 | 92 | 0.230 |
Why?
|
| Heart Valve Diseases | 1 | 2023 | 102 | 0.230 |
Why?
|
| American Heart Association | 1 | 2022 | 86 | 0.220 |
Why?
|
| Atrial Pressure | 1 | 2021 | 6 | 0.220 |
Why?
|
| Stroke Volume | 2 | 2021 | 433 | 0.220 |
Why?
|
| Mucormycosis | 1 | 2021 | 14 | 0.210 |
Why?
|
| Catheterization, Swan-Ganz | 1 | 2021 | 25 | 0.200 |
Why?
|
| Mineralocorticoid Receptor Antagonists | 1 | 2021 | 58 | 0.200 |
Why?
|
| Extracorporeal Membrane Oxygenation | 1 | 2023 | 137 | 0.200 |
Why?
|
| Torsion, Mechanical | 1 | 2020 | 6 | 0.200 |
Why?
|
| Troponin T | 1 | 2020 | 35 | 0.190 |
Why?
|
| Ventricular Function, Left | 2 | 2021 | 578 | 0.190 |
Why?
|
| Treatment Outcome | 4 | 2023 | 7825 | 0.190 |
Why?
|
| Prognosis | 3 | 2022 | 3622 | 0.180 |
Why?
|
| Tricuspid Valve Insufficiency | 1 | 2021 | 111 | 0.180 |
Why?
|
| Pulmonary Artery | 1 | 2021 | 294 | 0.180 |
Why?
|
| Retrospective Studies | 5 | 2023 | 8148 | 0.160 |
Why?
|
| Reoperation | 1 | 2020 | 585 | 0.160 |
Why?
|
| Male | 7 | 2022 | 40407 | 0.160 |
Why?
|
| Obesity, Morbid | 1 | 2020 | 217 | 0.160 |
Why?
|
| Thromboembolism | 1 | 2018 | 117 | 0.150 |
Why?
|
| Treatment Failure | 1 | 2017 | 283 | 0.150 |
Why?
|
| Magnetic Resonance Imaging, Cine | 1 | 2018 | 155 | 0.150 |
Why?
|
| Middle Aged | 5 | 2022 | 24734 | 0.150 |
Why?
|
| Cardiac Catheterization | 1 | 2018 | 285 | 0.150 |
Why?
|
| Electrocardiography | 1 | 2017 | 472 | 0.130 |
Why?
|
| Biomarkers | 1 | 2020 | 1668 | 0.130 |
Why?
|
| Tranexamic Acid | 1 | 2014 | 20 | 0.120 |
Why?
|
| Antifibrinolytic Agents | 1 | 2014 | 28 | 0.120 |
Why?
|
| Prevalence | 1 | 2018 | 1222 | 0.120 |
Why?
|
| Incidence | 1 | 2018 | 1559 | 0.120 |
Why?
|
| Blood Transfusion | 1 | 2014 | 154 | 0.120 |
Why?
|
| Echocardiography | 1 | 2018 | 895 | 0.110 |
Why?
|
| Adult | 3 | 2021 | 25247 | 0.110 |
Why?
|
| Arthroplasty, Replacement, Knee | 1 | 2014 | 110 | 0.110 |
Why?
|
| Female | 5 | 2022 | 43860 | 0.110 |
Why?
|
| Aged | 4 | 2022 | 18149 | 0.110 |
Why?
|
| Risk Factors | 2 | 2020 | 5305 | 0.100 |
Why?
|
| Anxiety | 1 | 2012 | 266 | 0.100 |
Why?
|
| Memory | 1 | 2012 | 225 | 0.100 |
Why?
|
| United States | 1 | 2022 | 6466 | 0.090 |
Why?
|
| Motivation | 1 | 2012 | 283 | 0.090 |
Why?
|
| Behavior, Animal | 1 | 2012 | 373 | 0.090 |
Why?
|
| Predictive Value of Tests | 2 | 2021 | 1643 | 0.070 |
Why?
|
| Thorax | 1 | 2023 | 68 | 0.060 |
Why?
|
| Amphotericin B | 1 | 2021 | 34 | 0.050 |
Why?
|
| Waiting Lists | 1 | 2023 | 172 | 0.050 |
Why?
|
| Aortic Valve | 1 | 2023 | 216 | 0.050 |
Why?
|
| Ventricular Pressure | 1 | 2021 | 31 | 0.050 |
Why?
|
| Antifungal Agents | 1 | 2021 | 116 | 0.050 |
Why?
|
| Immunocompromised Host | 1 | 2021 | 133 | 0.050 |
Why?
|
| Tricuspid Valve | 1 | 2021 | 96 | 0.050 |
Why?
|
| Heart | 1 | 2023 | 526 | 0.050 |
Why?
|
| Hospital Mortality | 1 | 2021 | 345 | 0.040 |
Why?
|
| Hospitals | 1 | 2021 | 276 | 0.040 |
Why?
|
| Heart Ventricles | 1 | 2023 | 750 | 0.040 |
Why?
|
| Sensitivity and Specificity | 1 | 2020 | 1971 | 0.040 |
Why?
|
| Pandemics | 1 | 2020 | 703 | 0.030 |
Why?
|
| Blood Loss, Surgical | 1 | 2014 | 110 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2020 | 2229 | 0.030 |
Why?
|
| Electroshock | 1 | 2012 | 17 | 0.030 |
Why?
|
| Rats, Long-Evans | 1 | 2012 | 51 | 0.030 |
Why?
|
| Conditioning, Classical | 1 | 2012 | 35 | 0.030 |
Why?
|
| Fear | 1 | 2012 | 70 | 0.030 |
Why?
|
| Odorants | 1 | 2012 | 69 | 0.030 |
Why?
|
| Sexual Behavior, Animal | 1 | 2012 | 92 | 0.030 |
Why?
|
| Aged, 80 and over | 1 | 2020 | 6454 | 0.020 |
Why?
|
| Double-Blind Method | 1 | 2014 | 1806 | 0.020 |
Why?
|
| Rats | 1 | 2012 | 3968 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2014 | 4089 | 0.020 |
Why?
|
| Animals | 1 | 2012 | 26190 | 0.010 |
Why?
|